Xenon Pharmaceuticals Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Xenon Pharmaceuticals Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2022.
  • Xenon Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $7.88M, a 93.4% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $354M, a 27% increase from 2022.
  • Xenon Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $278M, a 37.8% decline from 2021.
  • Xenon Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $448M, a 422% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $7.88M -$111M -93.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $119M +$16.3M +15.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $102M +$102M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $58K* -$61K Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-26
Q1 2018 $119K* Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.